Plus Therapeutics, Inc.
General ticker "PSTV" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $17.2M (TTM average)
Plus Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -1.1%.
Estimated limits based on current volatility of 7.7%: low 5.66$, high 6.61$
Factors to consider:
- Total employees count: 20 (+17.6%) as of 2023
- Top business risk factors: Insufficient funding, Market competition, Regulatory and compliance, Labor/talent shortage/retention, Cybersecurity threats
- Current price 14.5% below estimated low
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [7.48$, 22.95$]
- 2026-12-31 to 2027-12-31 estimated range: [5.78$, 18.34$]
Short-term PSTV quotes
Long-term PSTV plot with estimates
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | $5.21MM |
| Operating Expenses | $20.51MM |
| Operating Income | $-15.30MM |
| Non-Operating Income | $-7.09MM |
| Interest Expense | $3.61MM |
| R&D Expense | $8.38MM |
| Income(Loss) | $-22.39MM |
| Profit(Loss)* | $-22.39MM |
| Stockholders Equity | $4.00MM |
| Assets | $16.32MM |
| Operating Cash Flow | $-20.77MM |
| Capital expenditure | $0.07MM |
| Investing Cash Flow | $-0.85MM |
| Financing Cash Flow | $30.31MM |
| Earnings Per Share** | $-7.19 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.